About India Glycols Limited
Data last updated: 02 July 2026
India Glycols Limited is a public limited company based in Udham Singh Nagar, Uttarakhand, India. It specialises in specialty chemicals, a part of the broader chemicals and materials sector. Incorporated on 19 November 1983, the company has been in operation for over 43 years.
Registered with ROC Uttarakhand under CIN L24111UR1983PLC009097. Listed on BSE: 500201 and NSE: INDIAGLYCO.
Capital: an authorised share capital of ₹45 Cr and a paid-up capital of ₹33.51 Cr. It is led by directors including Uma Shankar Bhartia and Pragya Bhartia Barwale.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 1 Industrial Area Bazpur Road Kashipur, Udham Singh Nagar, Uttarakhand, India – 244713.
As per the financials filed for FY 2025, the company reported a revenue of ₹9,053.5 Cr, a growth of 14% compared to the previous year.
The company has a workforce of approximately 1,347 employees as per the latest available data. Its group structure includes 3 subsidiaries and 1 joint venture.
The company is associated with 3 brands - Ennature Biopharma, Principle Circle, India Glycols. As per MCA filings, the company has open charges of ₹3,185.68 Cr and satisfied charges of ₹12,932 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indiaglycols.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressA – 1 Industrial Area Bazpur Road Kashipur, Udham Singh Nagar, Uttarakhand, India – 244713
-
IndustryChemicals and Materials, Specialty Chemicals, Industrial & Specialty Gases
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of India Glycols Limited
India Glycols Limited has one previous CIN (Corporate Identification Number): L24111UP1983PLC009097. The current CIN is L24111UR1983PLC009097, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24111UR1983PLC009097 | Current |
| L24111UP1983PLC009097 | Previous |
Associated Brands with India Glycols Limited
India Glycols Limited operates multiple associated brands including Ennature Biopharma, Principle Circle, and India Glycols. These brands represent India Glycols Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies pure nicotine, pharmaceutical actives, and nutraceutical ingredients globally. | ennaturebiopharma.com | |
| Offers management consulting and innovative products in education and entertainment sectors. | principlecircle.com | |
| Bulk, specialty, and performance chemicals are supplied to various industries. | indiaglycols.com |
Competitors & Alternatives of India Glycols Limited
Brands and companies operating in the same space as India Glycols Limited include TeamLease, Laurus Labs, Cyient and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Staffing and recruiting services connect employers with job candidates. | Bengaluru, India, India | 2000 |
|
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
|
|
Provider of digital engineering and technology services | Hyderabad, India, India | 1991 |
|
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
|
|
Advisory, consulting, technology, and analytics solutions are provided across industries. | Amman, Jordan, Jordan | 2002 |
|
|
Phytochemicals are developed using microbial fermentation processes. | Cambridge, United States, United States | 2011 |
|
|
Waste carbon is treated via a bio-processing platform. | Skokie, United States, United States | 2005 |
|
|
Provider of software development, cloud & data management, and IT consulting services | United States | 1994 |
|
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
|
|
Business consulting, activation, and transformation services are provided. | Navi Mumbai, India, India | 2006 |
Business Activity of India Glycols Limited
India Glycols Limited is engaged in principal business activities including manufacturing and trade, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, wholesale trading. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
| G | Trade | G1 | Wholesale Trading | ********* |
Auditor Details of India Glycols Limited
India Glycols Limited is audited by M/s K N Gutgutia & Co. (ICAI peer reviewed, certificate valid till 2027-11-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s K N Gutgutia & Co. (ICAI peer reviewed, certificate valid till 2027-11-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of India Glycols Limited
India Glycols Limited is currently managed by 11 directors, with 23 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
Financials of India Glycols Limited FY 2026 filings available
India Glycols Limited reported revenue of ₹9,826.63 Cr (up 8.71% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹9,826.63 Cr | ₹9,038.95 Cr | ₹7,921.54 Cr | ₹6,641.64 Cr | ₹6,601.41 Cr | ₹5,427.47 Cr | ₹5,972.65 Cr |
| Other Income | ₹4.93 Cr | ₹14.55 Cr | ₹25.73 Cr | ₹23.89 Cr | ₹21.54 Cr | ₹15.26 Cr | ₹8.77 Cr |
| Total Income | ₹9,831.56 Cr | ₹9,053.5 Cr | ₹7,947.27 Cr | ₹6,665.53 Cr | ₹6,622.95 Cr | ₹5,442.73 Cr | ₹5,981.42 Cr |
| Cost of Materials Consumed | ₹2,412.43 Cr | ₹2,345.81 Cr | ₹1,818.92 Cr | ₹1,444.75 Cr | ₹1,666.94 Cr | ₹1,185.6 Cr | ₹1,685.7 Cr |
| Purchases of Stock-in-Trade | ₹187.22 Cr | ₹113.59 Cr | ₹321.8 Cr | ₹160.12 Cr | ₹351.37 Cr | ₹328.27 Cr | ₹630.89 Cr |
| Changes in Inventories | ₹62.35 Cr | -₹51.55 Cr | ₹8.11 Cr | -₹22.56 Cr | -₹96.89 Cr | -₹14.7 Cr | ₹11.62 Cr |
| Employee Benefit Expense | ₹132.61 Cr | ₹122.69 Cr | ₹103.37 Cr | ₹88.8 Cr | ₹89.16 Cr | ₹83.33 Cr | ₹114.38 Cr |
| Finance Costs | ₹167.18 Cr | ₹164.37 Cr | ₹120.67 Cr | ₹99.96 Cr | ₹69.66 Cr | ₹83.38 Cr | ₹143.41 Cr |
| Depreciation & Amortisation | ₹155.38 Cr | ₹115.2 Cr | ₹100.77 Cr | ₹93.96 Cr | ₹80.29 Cr | ₹80.12 Cr | ₹82.97 Cr |
| Other Expenses | ₹6,382.77 Cr | ₹5,997.47 Cr | ₹5,266.98 Cr | ₹4,675 Cr | ₹4,335.63 Cr | ₹3,576.97 Cr | ₹3,138.13 Cr |
| Total Expenses | ₹9,499.94 Cr | ₹8,807.58 Cr | ₹7,740.62 Cr | ₹6,540.03 Cr | ₹6,496.16 Cr | ₹5,322.97 Cr | ₹5,807.1 Cr |
| Profit Before Exceptional Items & Tax | ₹331.62 Cr | ₹245.92 Cr | ₹206.65 Cr | ₹125.5 Cr | ₹126.79 Cr | ₹119.76 Cr | ₹174.32 Cr |
| Exceptional Items | -₹83 Lakh | ₹0 | ₹0 | ₹28.13 Cr | ₹221.34 Cr | ₹0 | ₹0 |
| Profit Before Tax | ₹330.79 Cr | ₹245.92 Cr | ₹206.65 Cr | ₹153.63 Cr | ₹348.13 Cr | ₹119.76 Cr | ₹174.32 Cr |
| Total Tax Expense | ₹84.45 Cr | ₹61.4 Cr | ₹50.32 Cr | ₹23.96 Cr | ₹39.43 Cr | ₹11.28 Cr | ₹59.25 Cr |
| Net Profit | ₹292.76 Cr | ₹230.92 Cr | ₹172.99 Cr | ₹141.04 Cr | ₹339.85 Cr | ₹131.61 Cr | ₹114.66 Cr |
| attributable to Owners | ₹292.76 Cr | ₹230.92 Cr | ₹172.99 Cr | ₹125.08 Cr | ₹339.85 Cr | ₹131.61 Cr | ₹114.66 Cr |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹15.96 Cr | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | -₹1.62 Cr | -₹1.3 Cr | -₹19 Lakh | ₹40 Lakh | -₹47 Lakh | ₹3.05 Cr | -₹1.36 Cr |
| Total Comprehensive Income | ₹291.14 Cr | ₹229.62 Cr | ₹172.8 Cr | ₹141.44 Cr | ₹339.38 Cr | ₹134.66 Cr | ₹113.3 Cr |
| EBITDA (computed) | ₹654.18 Cr | ₹525.49 Cr | ₹428.09 Cr | ₹319.42 Cr | ₹276.74 Cr | ₹283.26 Cr | ₹400.7 Cr |
| Basic EPS | ₹45.95 | ₹74.58 | ₹55.87 | ₹45.55 | ₹106.45 | ₹35.27 | ₹37.03 |
| Diluted EPS | ₹45.95 | ₹74.58 | ₹55.87 | ₹45.55 | ₹106.45 | ₹35.27 | ₹37.03 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹6,522.95 Cr | ₹6,176.1 Cr | ₹5,616.8 Cr | ₹4,858.33 Cr |
| Non-current Assets | ₹5,025.14 Cr | ₹4,359.88 Cr | ₹3,672.1 Cr | ₹3,212.09 Cr |
| Current Assets | ₹1,497.81 Cr | ₹1,816.22 Cr | ₹1,944.7 Cr | ₹1,646.24 Cr |
| Property, Plant & Equipment | ₹4,551.29 Cr | ₹3,825.95 Cr | ₹3,196.77 Cr | ₹2,707.37 Cr |
| Inventories | ₹890.61 Cr | ₹1,170.88 Cr | ₹1,106.29 Cr | ₹753.83 Cr |
| Trade Receivables | ₹351.4 Cr | ₹364.97 Cr | ₹384.1 Cr | ₹430.34 Cr |
| Cash & Equivalents | ₹31.87 Cr | ₹6.84 Cr | ₹26.96 Cr | ₹1.97 Cr |
| Equity (Net Worth) | ₹2,932.78 Cr | ₹2,255.88 Cr | ₹2,051.02 Cr | ₹1,901.42 Cr |
| Equity Share Capital | ₹33.51 Cr | ₹30.96 Cr | ₹30.96 Cr | ₹30.96 Cr |
| Borrowings (Non-current) | ₹919.13 Cr | ₹1,040.09 Cr | ₹725.08 Cr | ₹550.77 Cr |
| Borrowings (Current) | ₹659.34 Cr | ₹764.18 Cr | ₹596.03 Cr | ₹543.3 Cr |
| Total Debt (computed) | ₹1,578.47 Cr | ₹1,804.27 Cr | ₹1,321.11 Cr | ₹1,094.07 Cr |
| Current Liabilities | ₹2,014.11 Cr | ₹2,321.04 Cr | ₹2,374.73 Cr | ₹1,864.93 Cr |
| Total Liabilities | ₹3,590.17 Cr | ₹3,920.22 Cr | ₹3,565.78 Cr | ₹2,956.91 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹769.17 Cr | ₹362.11 Cr | ₹438.51 Cr | ₹325.71 Cr | ₹91.42 Cr |
| Investing Cash Flow | -₹766.68 Cr | -₹735.99 Cr | -₹503.45 Cr | -₹330.28 Cr | ₹93.13 Cr |
| Financing Cash Flow | ₹22.54 Cr | ₹353.76 Cr | ₹89.93 Cr | -₹51 Lakh | -₹180.89 Cr |
| Capital Expenditure | ₹823.48 Cr | ₹760.47 Cr | ₹552.93 Cr | ₹438.77 Cr | ₹379.92 Cr |
| Free Cash Flow (computed) | -₹54.31 Cr | -₹398.36 Cr | -₹114.42 Cr | -₹113.06 Cr | -₹288.5 Cr |
| Dividends Paid | ₹75.31 Cr | ₹24.59 Cr | ₹22.97 Cr | ₹23.04 Cr | ₹18.39 Cr |
| Net Change in Cash | ₹25.03 Cr | -₹20.12 Cr | ₹24.99 Cr | -₹5.08 Cr | ₹3.66 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹2,360.01 Cr | ₹2,551.1 Cr | ₹2,412.4 Cr | ₹2,503.12 Cr | ₹2,188.65 Cr | ₹2,424.01 Cr | ₹2,143.71 Cr | ₹2,282.58 Cr | ₹2,039.08 Cr | ₹2,118.94 Cr | ₹1,869.88 Cr | ₹1,893.64 Cr |
| Other Income | ₹62 Lakh | ₹74 Lakh | ₹2.17 Cr | ₹1.4 Cr | ₹1.59 Cr | ₹5.82 Cr | ₹4.34 Cr | ₹2.8 Cr | ₹4.65 Cr | ₹4.55 Cr | ₹10.73 Cr | ₹5.8 Cr |
| Total Income | ₹2,360.63 Cr | ₹2,551.84 Cr | ₹2,414.57 Cr | ₹2,504.52 Cr | ₹2,190.24 Cr | ₹2,429.83 Cr | ₹2,148.05 Cr | ₹2,285.38 Cr | ₹2,043.73 Cr | ₹2,123.49 Cr | ₹1,880.61 Cr | ₹1,899.44 Cr |
| Cost of Materials Consumed | ₹484.66 Cr | ₹597.82 Cr | ₹660.85 Cr | ₹669.1 Cr | ₹488.26 Cr | ₹642.29 Cr | ₹584.28 Cr | ₹630.98 Cr | ₹501.46 Cr | ₹515.96 Cr | ₹407.33 Cr | ₹394.17 Cr |
| Purchases of Stock-in-Trade | ₹38.79 Cr | ₹40.84 Cr | ₹63.25 Cr | ₹44.34 Cr | ₹32.27 Cr | ₹25.39 Cr | ₹34.48 Cr | ₹21.45 Cr | ₹115.69 Cr | ₹114.16 Cr | ₹88.06 Cr | ₹3.89 Cr |
| Changes in Inventories | ₹83.51 Cr | ₹53.06 Cr | -₹38.25 Cr | -₹35.97 Cr | ₹13.36 Cr | -₹45.67 Cr | ₹6 Cr | -₹25.24 Cr | ₹18.61 Cr | -₹12.55 Cr | ₹1.87 Cr | ₹18 Lakh |
| Employee Benefit Expense | ₹34.21 Cr | ₹35.23 Cr | ₹32.11 Cr | ₹31.06 Cr | ₹30.56 Cr | ₹31.2 Cr | ₹30.28 Cr | ₹30.65 Cr | ₹29.94 Cr | ₹27.44 Cr | ₹23.18 Cr | ₹22.81 Cr |
| Finance Costs | ₹26.41 Cr | ₹46.81 Cr | ₹49.28 Cr | ₹44.68 Cr | ₹44.53 Cr | ₹44.07 Cr | ₹39.91 Cr | ₹35.86 Cr | ₹32.63 Cr | ₹31.41 Cr | ₹29.05 Cr | ₹27.58 Cr |
| Depreciation & Amortisation | ₹41.23 Cr | ₹41.22 Cr | ₹38.48 Cr | ₹34.45 Cr | ₹32.59 Cr | ₹27.47 Cr | ₹27.57 Cr | ₹27.57 Cr | ₹26.04 Cr | ₹26.24 Cr | ₹27.96 Cr | ₹20.53 Cr |
| Other Expenses | ₹1,552.34 Cr | ₹1,648.68 Cr | ₹1,536.8 Cr | ₹1,644.95 Cr | ₹1,478.26 Cr | ₹1,647.14 Cr | ₹1,372.89 Cr | ₹1,499.18 Cr | ₹1,268.8 Cr | ₹1,371.67 Cr | ₹1,253.93 Cr | ₹1,372.58 Cr |
| Total Expenses | ₹2,261.15 Cr | ₹2,463.66 Cr | ₹2,342.52 Cr | ₹2,432.61 Cr | ₹2,119.83 Cr | ₹2,371.89 Cr | ₹2,095.41 Cr | ₹2,220.45 Cr | ₹1,993.17 Cr | ₹2,074.33 Cr | ₹1,831.38 Cr | ₹1,841.74 Cr |
| Profit Before Exceptional Items & Tax | ₹99.48 Cr | ₹88.18 Cr | ₹72.05 Cr | ₹71.91 Cr | ₹70.41 Cr | ₹57.94 Cr | ₹52.64 Cr | ₹64.93 Cr | ₹50.56 Cr | ₹49.16 Cr | ₹49.23 Cr | ₹57.7 Cr |
| Exceptional Items | ₹0 | -₹83 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹99.48 Cr | ₹87.35 Cr | ₹72.05 Cr | ₹71.91 Cr | ₹70.41 Cr | ₹57.94 Cr | ₹52.64 Cr | ₹64.93 Cr | ₹50.56 Cr | ₹49.16 Cr | ₹49.23 Cr | ₹57.7 Cr |
| Total Tax Expense | ₹25.58 Cr | ₹23.04 Cr | ₹18.55 Cr | ₹17.28 Cr | ₹17.77 Cr | ₹14.61 Cr | ₹13.75 Cr | ₹15.27 Cr | ₹13.39 Cr | ₹12.26 Cr | ₹12.09 Cr | ₹12.58 Cr |
| Net Profit | ₹86.88 Cr | ₹67.57 Cr | ₹65.06 Cr | ₹73.25 Cr | ₹64.02 Cr | ₹56.81 Cr | ₹49.71 Cr | ₹60.38 Cr | ₹42.21 Cr | ₹41.63 Cr | ₹38.01 Cr | ₹51.14 Cr |
| attributable to Owners | ₹86.88 Cr | - | ₹65.06 Cr | ₹73.25 Cr | ₹64.02 Cr | - | ₹49.71 Cr | ₹60.38 Cr | ₹42.21 Cr | ₹41.63 Cr | ₹38.01 Cr | ₹51.14 Cr |
| attributable to NCI | ₹0 | - | - | ₹0 | ₹0 | - | - | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | -₹80 Lakh | -₹25 Lakh | -₹14 Lakh | -₹43 Lakh | -₹76 Lakh | -₹42 Lakh | -₹7 Lakh | -₹5 Lakh | -₹14 Lakh | ₹51 Lakh | -₹38 Lakh | -₹18 Lakh |
| Total Comprehensive Income | ₹86.08 Cr | ₹67.32 Cr | ₹64.92 Cr | ₹72.82 Cr | ₹63.26 Cr | ₹56.39 Cr | ₹49.64 Cr | ₹60.33 Cr | ₹42.07 Cr | ₹42.14 Cr | ₹37.63 Cr | ₹50.96 Cr |
| EBITDA (computed) | ₹167.12 Cr | ₹176.21 Cr | ₹159.81 Cr | ₹151.04 Cr | ₹147.53 Cr | ₹129.48 Cr | ₹120.12 Cr | ₹128.36 Cr | ₹109.23 Cr | ₹106.81 Cr | ₹106.24 Cr | ₹105.81 Cr |
| Basic EPS | ₹13.64 | ₹10.79 | ₹10.51 | ₹23.66 | ₹20.68 | ₹18.35 | ₹16.06 | ₹19.50 | ₹13.63 | ₹13.45 | ₹12.27 | ₹16.52 |
| Diluted EPS | ₹13.64 | ₹10.79 | ₹10.51 | ₹23.66 | ₹20.68 | ₹18.35 | ₹16.06 | ₹19.50 | ₹13.63 | ₹13.45 | ₹12.27 | ₹16.52 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Bio-based Specialities and Performance Chemicals | ₹301.16 Cr | ₹36.76 Cr | ₹3,600.59 Cr | ₹737.97 Cr |
| Potable Spirits | ₹1,690.09 Cr | ₹67.78 Cr | ₹596.6 Cr | ₹326.53 Cr |
| Ennature Biopharma | ₹63.49 Cr | ₹3.01 Cr | ₹426.42 Cr | ₹92.49 Cr |
| Bio-Fuel | ₹305.27 Cr | ₹30.21 Cr | ₹1,429.96 Cr | ₹92.27 Cr |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Bio-based Specialities and Performance Chemicals | ₹1,202.5 Cr | ₹140.95 Cr | - | - |
| Potable Spirits | ₹6,946.43 Cr | ₹284.93 Cr | - | - |
| Ennature Biopharma | ₹207.77 Cr | ₹7.23 Cr | - | - |
| Bio-Fuel | ₹1,469.93 Cr | ₹115.23 Cr | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹9,826.2 Cr | ₹9,037.82 Cr | ₹7,918.77 Cr | ₹6,640.86 Cr | ₹6,596.33 Cr | ₹5,390 Cr | ₹5,951.17 Cr |
| Other Income | ₹43.51 Cr | ₹14.55 Cr | ₹25.73 Cr | ₹27.59 Cr | ₹26.53 Cr | ₹12.08 Cr | ₹12.18 Cr |
| Total Income | ₹9,869.71 Cr | ₹9,052.37 Cr | ₹7,944.5 Cr | ₹6,668.45 Cr | ₹6,622.86 Cr | ₹5,402.08 Cr | ₹5,963.35 Cr |
| Cost of Materials Consumed | ₹2,412.43 Cr | ₹2,345.81 Cr | ₹1,818.92 Cr | ₹1,444.75 Cr | ₹1,666.94 Cr | ₹1,185.6 Cr | ₹1,685.7 Cr |
| Purchases of Stock-in-Trade | ₹188.46 Cr | ₹111.8 Cr | ₹319.68 Cr | ₹159.49 Cr | ₹350.36 Cr | ₹300.9 Cr | ₹610.87 Cr |
| Changes in Inventories | ₹60.92 Cr | -₹50.46 Cr | ₹7.66 Cr | -₹22.13 Cr | -₹96.89 Cr | -₹14.4 Cr | ₹11.36 Cr |
| Employee Benefit Expense | ₹130.69 Cr | ₹120.89 Cr | ₹101.62 Cr | ₹87.13 Cr | ₹87.59 Cr | ₹81.69 Cr | ₹112.48 Cr |
| Finance Costs | ₹167.18 Cr | ₹164.37 Cr | ₹120.67 Cr | ₹95.19 Cr | ₹62.17 Cr | ₹73.45 Cr | ₹136.76 Cr |
| Depreciation & Amortisation | ₹155.38 Cr | ₹115.19 Cr | ₹100.76 Cr | ₹89.65 Cr | ₹75.98 Cr | ₹75.81 Cr | ₹78.64 Cr |
| Other Expenses | ₹6,387.12 Cr | ₹6,002.99 Cr | ₹5,273.14 Cr | ₹4,674.1 Cr | ₹4,335.96 Cr | ₹3,578.71 Cr | ₹3,140.03 Cr |
| Total Expenses | ₹9,502.18 Cr | ₹8,810.59 Cr | ₹7,742.45 Cr | ₹6,528.18 Cr | ₹6,482.11 Cr | ₹5,281.76 Cr | ₹5,775.84 Cr |
| Profit Before Exceptional Items & Tax | ₹367.53 Cr | ₹241.78 Cr | ₹202.05 Cr | ₹140.27 Cr | ₹140.75 Cr | ₹120.32 Cr | ₹187.51 Cr |
| Exceptional Items | -₹83 Lakh | ₹0 | ₹0 | -₹17.57 Cr | ₹200.63 Cr | ₹0 | ₹0 |
| Profit Before Tax | ₹366.7 Cr | ₹241.78 Cr | ₹202.05 Cr | ₹122.7 Cr | ₹341.38 Cr | ₹120.32 Cr | ₹187.51 Cr |
| Total Tax Expense | ₹84.37 Cr | ₹61.4 Cr | ₹50.32 Cr | ₹23.96 Cr | ₹66.26 Cr | ₹58.43 Cr | ₹59.25 Cr |
| Net Profit | ₹282.33 Cr | ₹180.38 Cr | ₹151.73 Cr | ₹98.74 Cr | ₹285.39 Cr | ₹84.3 Cr | ₹128.26 Cr |
| Other Comprehensive Income | -₹1.7 Cr | -₹87 Lakh | ₹19 Lakh | ₹34 Lakh | -₹7 Lakh | ₹2.95 Cr | -₹11.37 Lakh |
| Total Comprehensive Income | ₹280.63 Cr | ₹179.51 Cr | ₹151.92 Cr | ₹99.08 Cr | ₹285.32 Cr | ₹87.25 Cr | ₹128.15 Cr |
| EBITDA (computed) | ₹690.09 Cr | ₹521.34 Cr | ₹423.48 Cr | ₹325.11 Cr | ₹278.9 Cr | ₹269.58 Cr | ₹402.91 Cr |
| Basic EPS | ₹44.31 | ₹58.26 | ₹49.01 | ₹31.89 | ₹88.86 | ₹19.99 | ₹41.43 |
| Diluted EPS | ₹44.31 | ₹58.26 | ₹49.01 | ₹31.89 | ₹88.86 | ₹19.99 | ₹41.43 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹6,126.12 Cr | ₹5,790.4 Cr | ₹5,281.12 Cr | ₹4,543.48 Cr |
| Non-current Assets | ₹4,636.39 Cr | ₹3,978.61 Cr | ₹3,336.98 Cr | ₹2,895.18 Cr |
| Current Assets | ₹1,489.73 Cr | ₹1,811.79 Cr | ₹1,944.14 Cr | ₹1,648.3 Cr |
| Property, Plant & Equipment | ₹4,551.29 Cr | ₹3,825.95 Cr | ₹3,196.76 Cr | ₹2,707.36 Cr |
| Inventories | ₹887.99 Cr | ₹1,168.8 Cr | ₹1,103.7 Cr | ₹753.05 Cr |
| Trade Receivables | ₹352.66 Cr | ₹366.04 Cr | ₹389.45 Cr | ₹436.26 Cr |
| Cash & Equivalents | ₹31.06 Cr | ₹6.51 Cr | ₹26.75 Cr | ₹1.81 Cr |
| Equity (Net Worth) | ₹2,537.44 Cr | ₹1,871.04 Cr | ₹1,716.3 Cr | ₹1,587.61 Cr |
| Equity Share Capital | ₹33.51 Cr | ₹30.96 Cr | ₹30.96 Cr | ₹30.96 Cr |
| Borrowings (Non-current) | ₹919.13 Cr | ₹1,040.09 Cr | ₹725.08 Cr | ₹550.77 Cr |
| Borrowings (Current) | ₹659.34 Cr | ₹764.18 Cr | ₹596.03 Cr | ₹543.3 Cr |
| Total Debt (computed) | ₹1,578.47 Cr | ₹1,804.27 Cr | ₹1,321.11 Cr | ₹1,094.07 Cr |
| Current Liabilities | ₹2,012.62 Cr | ₹2,320.18 Cr | ₹2,373.77 Cr | ₹1,863.89 Cr |
| Total Liabilities | ₹3,588.68 Cr | ₹3,919.36 Cr | ₹3,564.82 Cr | ₹2,955.87 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹768.99 Cr | ₹361.99 Cr | ₹438.46 Cr | ₹325.91 Cr | ₹89.75 Cr |
| Investing Cash Flow | -₹766.98 Cr | -₹735.99 Cr | -₹503.45 Cr | -₹330.32 Cr | ₹93.48 Cr |
| Financing Cash Flow | ₹22.54 Cr | ₹353.76 Cr | ₹89.93 Cr | -₹42 Lakh | -₹179.59 Cr |
| Capital Expenditure | -₹6.86 Cr | -₹7.71 Cr | -₹10.92 Cr | -₹4.11 Cr | ₹379.92 Cr |
| Free Cash Flow (computed) | ₹762.13 Cr | ₹354.28 Cr | ₹427.54 Cr | ₹321.8 Cr | -₹290.17 Cr |
| Dividends Paid | ₹75.31 Cr | ₹24.59 Cr | ₹22.97 Cr | ₹23.04 Cr | ₹18.39 Cr |
| Net Change in Cash | ₹24.55 Cr | -₹20.24 Cr | ₹24.94 Cr | -₹4.83 Cr | ₹3.64 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹2,361.4 Cr | ₹2,551.06 Cr | ₹2,410.71 Cr | ₹2,503.03 Cr | ₹2,188 Cr | ₹2,423.76 Cr | ₹2,143.63 Cr | ₹2,282.43 Cr | ₹2,036.57 Cr | ₹2,119.19 Cr | ₹1,870.64 Cr | ₹1,892.37 Cr |
| Other Income | ₹39.2 Cr | ₹74 Lakh | ₹2.17 Cr | ₹1.4 Cr | ₹1.59 Cr | ₹5.82 Cr | ₹4.34 Cr | ₹2.8 Cr | ₹4.65 Cr | ₹4.55 Cr | ₹10.73 Cr | ₹5.8 Cr |
| Total Income | ₹2,400.6 Cr | ₹2,551.8 Cr | ₹2,412.88 Cr | ₹2,504.43 Cr | ₹2,189.59 Cr | ₹2,429.58 Cr | ₹2,147.97 Cr | ₹2,285.23 Cr | ₹2,041.22 Cr | ₹2,123.74 Cr | ₹1,881.37 Cr | ₹1,898.17 Cr |
| Cost of Materials Consumed | ₹484.66 Cr | ₹597.82 Cr | ₹660.85 Cr | ₹669.1 Cr | ₹488.26 Cr | ₹642.29 Cr | ₹584.28 Cr | ₹630.98 Cr | ₹501.46 Cr | ₹515.96 Cr | ₹407.33 Cr | ₹394.17 Cr |
| Purchases of Stock-in-Trade | ₹40.25 Cr | ₹40.81 Cr | ₹63.21 Cr | ₹44.19 Cr | ₹30.59 Cr | ₹25.34 Cr | ₹34.48 Cr | ₹21.39 Cr | ₹113.35 Cr | ₹114.11 Cr | ₹91 Cr | ₹1.22 Cr |
| Changes in Inventories | ₹83.51 Cr | ₹53.07 Cr | -₹39.69 Cr | -₹35.97 Cr | ₹14.44 Cr | -₹45.66 Cr | ₹6 Cr | -₹25.24 Cr | ₹18.61 Cr | -₹12.56 Cr | ₹22 Lakh | ₹1.39 Cr |
| Employee Benefit Expense | ₹33.68 Cr | ₹34.77 Cr | ₹31.64 Cr | ₹30.6 Cr | ₹30.1 Cr | ₹30.76 Cr | ₹29.82 Cr | ₹30.21 Cr | ₹29.5 Cr | ₹27.01 Cr | ₹22.74 Cr | ₹22.37 Cr |
| Finance Costs | ₹26.41 Cr | ₹46.81 Cr | ₹49.28 Cr | ₹44.68 Cr | ₹44.53 Cr | ₹44.07 Cr | ₹39.91 Cr | ₹35.86 Cr | ₹32.63 Cr | ₹31.41 Cr | ₹29.05 Cr | ₹27.58 Cr |
| Depreciation & Amortisation | ₹41.23 Cr | ₹41.22 Cr | ₹38.48 Cr | ₹34.45 Cr | ₹32.59 Cr | ₹27.46 Cr | ₹27.58 Cr | ₹27.56 Cr | ₹26.03 Cr | ₹26.25 Cr | ₹27.95 Cr | ₹20.53 Cr |
| Other Expenses | ₹1,555.08 Cr | ₹1,648.17 Cr | ₹1,536.62 Cr | ₹1,647.25 Cr | ₹1,480.96 Cr | ₹1,646.87 Cr | ₹1,372.7 Cr | ₹1,502.46 Cr | ₹1,268.51 Cr | ₹1,371.51 Cr | ₹1,255.32 Cr | ₹1,377.8 Cr |
| Total Expenses | ₹2,264.82 Cr | ₹2,462.67 Cr | ₹2,340.39 Cr | ₹2,434.3 Cr | ₹2,121.47 Cr | ₹2,371.13 Cr | ₹2,094.77 Cr | ₹2,223.22 Cr | ₹1,990.09 Cr | ₹2,073.69 Cr | ₹1,833.61 Cr | ₹1,845.06 Cr |
| Profit Before Exceptional Items & Tax | ₹135.78 Cr | ₹89.13 Cr | ₹72.49 Cr | ₹70.13 Cr | ₹68.12 Cr | ₹58.45 Cr | ₹53.2 Cr | ₹62.01 Cr | ₹51.13 Cr | ₹50.05 Cr | ₹47.76 Cr | ₹53.11 Cr |
| Exceptional Items | ₹0 | -₹83 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹135.78 Cr | ₹88.3 Cr | ₹72.49 Cr | ₹70.13 Cr | ₹68.12 Cr | ₹58.45 Cr | ₹53.2 Cr | ₹62.01 Cr | ₹51.13 Cr | ₹50.05 Cr | ₹47.76 Cr | ₹53.11 Cr |
| Total Tax Expense | ₹25.5 Cr | ₹23.04 Cr | ₹18.55 Cr | ₹17.28 Cr | ₹17.77 Cr | ₹14.61 Cr | ₹13.75 Cr | ₹15.27 Cr | ₹13.39 Cr | ₹12.26 Cr | ₹12.09 Cr | ₹12.58 Cr |
| Net Profit | ₹110.28 Cr | ₹65.26 Cr | ₹53.94 Cr | ₹52.85 Cr | ₹50.35 Cr | ₹43.84 Cr | ₹39.45 Cr | ₹46.74 Cr | ₹37.74 Cr | ₹37.79 Cr | ₹35.67 Cr | ₹40.53 Cr |
| Other Comprehensive Income | -₹1.14 Cr | -₹19 Lakh | -₹18 Lakh | -₹19 Lakh | -₹98 Lakh | ₹4 Lakh | ₹3 Lakh | ₹4 Lakh | ₹8 Lakh | ₹4 Lakh | ₹4 Lakh | ₹3 Lakh |
| Total Comprehensive Income | ₹109.14 Cr | ₹65.07 Cr | ₹53.76 Cr | ₹52.66 Cr | ₹49.37 Cr | ₹43.88 Cr | ₹39.48 Cr | ₹46.78 Cr | ₹37.82 Cr | ₹37.83 Cr | ₹35.71 Cr | ₹40.56 Cr |
| EBITDA (computed) | ₹203.42 Cr | ₹177.16 Cr | ₹160.25 Cr | ₹149.26 Cr | ₹145.24 Cr | ₹129.98 Cr | ₹120.69 Cr | ₹125.43 Cr | ₹109.79 Cr | ₹107.71 Cr | ₹104.76 Cr | ₹101.22 Cr |
| Basic EPS | ₹17.31 | ₹10.42 | ₹8.71 | ₹17.07 | ₹16.26 | ₹14.16 | ₹12.74 | ₹15.10 | ₹12.19 | ₹12.21 | ₹11.52 | ₹13.09 |
| Diluted EPS | ₹17.31 | ₹10.42 | ₹8.71 | ₹17.07 | ₹16.26 | ₹14.16 | ₹12.74 | ₹15.10 | ₹12.19 | ₹12.21 | ₹11.52 | ₹13.09 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Bio-based Specialities and Performance Chemicals | ₹302.55 Cr | ₹34.47 Cr | ₹3,595.99 Cr | ₹737.05 Cr |
| Potable Spirits | ₹1,690.09 Cr | ₹67.78 Cr | ₹596.6 Cr | ₹326.53 Cr |
| Ennature Biopharma | ₹63.49 Cr | ₹3.01 Cr | ₹426.42 Cr | ₹92.49 Cr |
| Bio-Fuel | ₹305.27 Cr | ₹30.21 Cr | ₹1,429.96 Cr | ₹92.27 Cr |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Bio-based Specialities and Performance Chemicals | ₹1,202.07 Cr | ₹138.27 Cr | - | - |
| Potable Spirits | ₹6,946.43 Cr | ₹284.93 Cr | - | - |
| Ennature Biopharma | ₹207.77 Cr | ₹7.23 Cr | - | - |
| Bio-Fuel | ₹1,469.93 Cr | ₹115.23 Cr | - | - |
Shareholding Pattern of India Glycols Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 59.63%, foreign institutional investors hold 2.27%, domestic institutional investors hold 5.20%, retail and other public shareholders hold 32.90% of India Glycols Limited. The company had 52,848 shareholders on record.
| Mar 2026 | Dec 2025 | Nov 2025 | Sep 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Promoters | 59.63% | 59.63% | 59.63% | 61.01% | 61.01% | 61.01% |
| Public | 40.37% | 40.37% | 40.37% | 38.99% | 38.99% | 38.99% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 59.63% | 61.01% | 61.01% | 61.01% | 61.02% | 61.02% | 61.02% | 61.01% | 61.01% | 61.07% | 61.07% |
| Public | 40.37% | 38.99% | 38.99% | 38.99% | 39.00% | 38.98% | 38.99% | 38.99% | 38.99% | 38.93% | 38.93% |
| Promoter change (YoY, %pts) | -1.38 | +0.00 | +0.00 | -0.01 | +0.00 | +0.00 | +0.01 | +0.00 | -0.06 | +0.00 | - |
Board & Governance of India Glycols Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of India Glycols Limited has 8 directors - 4 independent and 3 executive. The board is chaired by UMA SHANKAR BHARTIA.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| UMA SHANKAR BHARTIA | Executive Director · MD · Chairperson | 1996-11-29 | 2 |
| JAYSHREE BHARTIA | Non-Executive - Non Independent Director | 1999-05-28 | 1 |
| SHUKLA WASSAN | Non-Executive - Independent Director | 2020-04-01 | 3 |
| PRAGYA BHARTIA BARWALE | Executive Director | 2020-06-24 | 2 |
| ALOK SINGHAL | Executive Director | 2023-12-01 | 1 |
| RAVI KUMAR | Non-Executive - Independent Director | 2024-02-02 | 3 |
| SAMRAT BANERJEE | Non-Executive - Independent Director | 2024-10-01 | 1 |
| SUSHIL DUTT SALWAN | Non-Executive - Independent Director | 2024-10-01 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | RAVI KUMAR (Chairperson), SAMRAT BANERJEE, ALOK SINGHAL |
| Nomination and remuneration committee | RAVI KUMAR (Chairperson), SHUKLA WASSAN, SUSHIL DUTT SALWAN |
| Stakeholders Relationship Committee | SHUKLA WASSAN (Chairperson), SAMRAT BANERJEE, UMA SHANKAR BHARTIA |
| Risk Management Committee | UMA SHANKAR BHARTIA (Chairperson), PRAGYA BHARTIA BARWALE, RAVI KUMAR, SHUKLA WASSAN, ALOK SINGHAL, RUPARK SARSWAT, ANAND SINGHAL, ATUL GOVIL |
| Corporate Social Responsibility Committee | UMA SHANKAR BHARTIA (Chairperson), PRAGYA BHARTIA BARWALE, SAMRAT BANERJEE, ALOK SINGHAL |
Group Structure of India Glycols Limited
India Glycols Limited has 3 subsidiary companies, 1 joint venture, and 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects India Glycols Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Igl Chemicals And Services Private Limited | U24200UR2021PTC012141 | - |
| Ennature Bio Pharma Private Limited | U24290UR2021PTC013005 | - |
| Igl Finance Limited | U65922UR1997PLC022992 | - |
Showing major subsidiaries. Total: 3.
Charges & Borrowings of India Glycols Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 May 2026 | Others | ₹25 Cr | Open |
| 11 Mar 2026 | Others | ₹16 Lakh | Open |
| 11 Mar 2026 | Others | ₹18 Lakh | Open |
| 06 Feb 2026 | Others | ₹28 Lakh | Open |
| 22 Jan 2026 | Others | ₹157 Cr | Open |
Total charge records: 214 View all charges
Employees and EPFO Compliance at India Glycols Limited
India Glycols Limited has a workforce of 1,347 employees as of Mar 26, 2024.
Employee Count & EPFO Data of India Glycols Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of India Glycols Limited
GSTIN & GST Filing Data of India Glycols Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for India Glycols Limited
Credit Ratings, Legal Cases & Regulatory Alerts of India Glycols Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by India Glycols Limited
MSME Payment Delays by India Glycols Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of India Glycols Limited
Subsidiaries & Group Companies of India Glycols Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of India Glycols Limited with ownership details.
MCA Filings & Documents of India Glycols Limited
MCA Filings & Documents of India Glycols Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on India Glycols Limited
Recent News on India Glycols Limited
Frequently Asked Questions about India Glycols Limited
India Glycols Limited is an active public limited company in the chemicals and materials sector based in Udham Singh Nagar, Uttarakhand, India. It was incorporated on 19 November 1983 (43+ years old) and is registered under CIN L24111UR1983PLC009097. Listed on BSE: 500201 and NSE: INDIAGLYCO. The company has 1,347 employees.
India Glycols Limited reported revenue of ₹9,053.5 Cr for FY 2025 (up 14.00% YoY).
The current directors of India Glycols Limited are:
- Uma Shankar Bhartia
- Pragya Bhartia Barwale
- Rupark Chandi Sarswat
- Shukla Wassan
- Ankur Jain
- Jayshree Bhartia
- Anand Singhal
- Samrat Banerjee
- Sushil Dutt Salwan
- Alok Singhal
- Ravi Kumar
The primary industry of India Glycols Limited is chemicals and materials. The company specifically operates in specialty chemicals. The company is currently active in this sector.
Yes. India Glycols Limited is listed on both BSE (code: 500201) and NSE (symbol: INDIAGLYCO).
India Glycols Limited can be reached at the registered office: A – 1 Industrial Area Bazpur Road Kashipur, Udham Singh Nagar, Uttarakhand, India – 244713, or through the website indiaglycols.com.